[1]
CicchettiA., AddessoD., LeoneF., AmatoA., AngerameL., D’AversaA., FraticelliM., NicoraC., SfreddoE., FumarolaM., PorcinoR., CoccioloG., ReS. and ScaccabarozziS. 2020. Valorization of clinical trials from the Italian National Health Service perspective: definition and first application of a model to estimate avoided costs. Global & Regional Health Technology Assessment. 7, 1 (Jun. 2020), 26-32. DOI:https://doi.org/10.33393/grhta.2020.709.